The isolated blood-perfused rat heart: An inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation

British Journal of Pharmacology

Volumn 137, Issue 7, 2002, Pages 1089-1099

  Clements Jewery, Hugh ^a   Hearse, David J ^a   Curtis, Michael J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Arrhythmias; Blood; Heart; Ischaemia; Neutrophil; Platelets; Rat; Ventricular fibrillation

Indexed keywords

MYELOPEROXIDASE; POTASSIUM ION; GELATIN; GELATIN SUCCINATE; PEROXIDASE; PLASMA SUBSTITUTE; SUCCINIC ACID DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; BLOOD CELL; BLOOD COMPONENT; CELL COUNT; CONTROLLED STUDY; ENZYME ACTIVITY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; ISOLATED HEART; LEFT CORONARY ARTERY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; ENZYMOLOGY; HEART; HEART ARRHYTHMIA; HEART RATE; HEART VENTRICLE; HEMODYNAMICS; IN VITRO STUDY; LEUKOCYTE COUNT; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; THROMBOCYTE COUNT; WISTAR RAT;

ANIMALS; ARRHYTHMIA; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; GELATIN; HEART; HEART RATE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; LEUKOCYTE COUNT; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PERFUSION; PEROXIDASE; PLASMA SUBSTITUTES; PLATELET COUNT; RATS; RATS, WISTAR; SUCCINATES; VENTRICULAR FIBRILLATION;

EID: 0036898840     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704977     Document Type: Article

References (55)

1. Allan, G., Bhattacherjee, P., Brook, C.D., Read, N.G. & Parke, A.J. (1985). Myeloperoxidase activity as a quantitative marker of polymorphonuclear leukocyte accumulation into an experimental myocardial infarct-the effect of ibuprofen on infarct size and polymorphonuclear leukocyte accumulation. J. Cardiovasc. Pharmacol., 7, 1154-1160.
2. Butler, J., Rocker, G.M. & Westaby, S. (1993). Inflammatory response to cardiopulmonary bypass. Ann. Thorac. Surg., 55, 552-559.
3. CAST. (1989). Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N. Engl. J. Med., 321, 406-412.
4. Clark, C., Foreman, M.I., Kane, K.A., MacDonald, F.M. & Parratt, J.R. (1980). Coronary artery ligation in anaesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J. Pharmacol. Methods, 3, 357-368.
5. Clements-Jewery, H., Hearse, D.J. & Curtis, M.J. (2002). Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart. Br. J. Pharmacol., 135, 807-815.
6. Cugno, M., Nussberger, J., Biglioli, P., Giovagnoni, M.G., Gardinali, M. & Agostoni, A. (1999). Cardiopulmonary bypass increases plasma bradykinin concentrations. Immunopharmacology, 43, 145-147.
7. Curtis, M.J. (1998). Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovasc. Res., 39, 194-215.
8. Curtis, M.J. & Hearse, D.J. (1989a). Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: Implications for mechanisms of initiation and maintenance of ventricular fibrillation. J. Mol. Cell Cardiol., 21, 21-40,
9. Curtis, M.J. & Hearse, D.J. (1989b). Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: Relevance to the mechanism of arrhythmogenesis. J. Mol. Cell. Cardiol., 21, 625-637.
10. Curtis, M.J., Johnston, K.M. & Walker, M.J.A. (1985a). Arrhythmias and serum potassium during myocardial ischaemia. ICRS Med. Sci. Res., 13, 688-689.
11. Curtis, M.J., MacLeod, B.A. & Walker, M.J. (1984). Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat. Br. J. Pharmacol., 83, 373-385.
12. Curtis, M.J., MacLeod, B.A. & Walker, M.J. (1985b). The effects of ablations in the central nervous system on arrhythmias induced by coronary occlusion in the rat. Br. J. Pharmacol., 86, 663-670.
13. Curtis, M.J., MacLeod, B.A. & Walker, M.J. (1987). Models for the study of arrhythmias in myocardial ischaemia and infarction: The use of the rat. J. Mol. Cell. Cardiol., 19, 399-419.
14. Curtis, M.J., Pugsley, M.K. & Walker, M.J. (1993). Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease. Cardiovasc. Res., 27, 703-719.
15. Curtis, M.J. & Walker, M.J. (1988a). The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia' studies with nifedipine and DHM9. Br. J. Pharmacol., 94, 1275-1286.
16. Curtis, M.J. & Walker, M.J. (1988b). Quantification of arrhythmias using scoring systems: An examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc. Res., 22, 656-665.
17. Downing, S.W. & Edmunds, Jr, L.H. (1992). Release of vasoactive substances during cardiopulmonary bypass. Ann. Thorac. Surg., 54, 1236-1243.
18. Engler, R.L., Dahlgren, M.D., Peterson, M.A., Dobbs, A. & Schmid-Schonbein, G.W. (1986). Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am. J. Physiol., 251, H93-H100.
19. Entman, M.L., Kukielka, G.L., Ballantyne, C.M. & Smith, C.W. (1993). The role of leukocytes in ischaemic heart disease. In Immunopharmacology of the Heart. ed. Curtis, M.J. pp. 55-74. UK: Academic Press.
20. Galinanes, M., Bernocchi, P., Argano, V., Cargnoni, A., Ferrari, R. & Hearse, D.J. (1996). Dichotomy in the postischemic metabolic and functional recovery profiles of isolated blood versus buffer-perfused heart. J. Mol. Cell Cardiol., 28, 531-539.
21. Galinanes, M., Lawson, C.S., Ferrari, R., Limb, G.A., Derias, N.W. & Hearse, D.J. (1993). Early and late effects of leukopenic reperfusion on the recovery of cardiac contractile function. Studies in the transplanted and isolated blood-perfused rat heart. Circulation, 88, 673-683.
22. Harris, A.S., Bisteni, A., Russell, R.A., Brigham, J.C. & Firestone, J.E. (1954). Excitatory factors in ventricular tachycardia resulting from myocardial ischemia. Potassium as a major excitant. Science, 119, 200-203.
23. Hearse, D.J., Ferrari, R. & Sutherland, F.J. (1999). Cardio-protection: Intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart. J. Mol. Cell Cardiol., 31, 1961-1973.
24. Janse, M.J. (1991). Re-entry rhythms. In The Heart and Cardiovascular System. ed. Fozzard, H.A. pp. 2055-2094. New York: Raven press.
25. Johnston, K.M., MacLeod, B.A. & Walker, M.J.A. (1983). Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Canad. J. Phys. Pharm., 61, 1340-1353.
26. Kolocassides, K.G., Galinanes, M. & Hearse, D.J. (1995). Preconditioning accelerates contracture and ATP depletion in blood-perfused rat hearts. Am. J. Physiol., 269, H1415-H1420.
27. Kreutzer, U. & Jue, T. (1995). Critical intracellular O2 in myocardium as determined by 1H nuclear magnetic resonance signal of myoglobin. Am. J. Physiol., 268, H1675-H1681.
28. Lajos, T.Z., Venditti, Jr, J. & Venuto, R. (1985). Hemodynamic consequences of bronchial flow during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., 89, 934-941.
29. Lamon, E.W., Bethard, A., Powell, Jr, T.J. & Blackstone, E.H. (1990). Invited letter concerning: Hemolysis after cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., 99, 751-752.
30. Lawson, C.S. (1993). Ischaemic preconditioning, arrhythmias and post-ischaemic contractile dysfunction in rat hearts in vitro and in vivo. In Cardiovascular Research, The Rayne Institute, St Thomas' Hospital. pp. 263. London: University of London.
31. Lawson, C.S., Coltart, D.J. & Hearse, D.J. (1993). "Dose"-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J. Mol. Cell. Cardiol., 25, 1391-1402.
32. Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
33. Mainland, D., Herrera, L. & Sutcliffe, M.I. (1956). Statistical Tables for use With Binomial Samples-Contingency Tests, Confidence limits and Sample Size Estimates. New York: University College of Medicine Publications.
34. Marath, A., Man, W. & Taylor, K.M. (1987). Histamine release in paediatric cardiopulmonary bypass-a possible role in the capillary leak syndrome. Agents Actions, 20, 299-302.
35. Maxwell, M.P., Hearse, D.J. & Yellon, D.M. (1987). Species variation in the coronary circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovas. Res., 21, 737-746.
36. McDonough, A.A., Thompson, C.B. & Youn, J.H. (2002). Skeletal muscle regulates extracellular potassium. Am. J. Physiol. Renal. Physiol., 282, F967-F974.
37. Mertz, T.E. & Kaplan, H.R. (1982). Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: Effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats. J. Pharmacol. Exp. Ther., 223, 580-586.
38. Mullane, K.M., Kraemer, R. & Smith, B. (1985). Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods, 14, 157-167.
39. Nagaoka, H., Yamada, T., Hatano, R., Tsukuura, T. & Sakamoto, T. (1975). Clinical significance of bradykinin liberation during cardiopulmonary bypass and its prevention by a kallikrein inhibitor. Jpn. J. Surg., 5, 222-233.
40. Nordrehaug, J.E. & Von der Lippe, G. (1983). Hypokalaemia and ventricular fibrillation in acute myocardial infarction. Br. Heart J., 50, 525-529.
41. Parratt, J. (1993). Endogenous myocardial protective (antiarrhythmic) substances. Cardiovasc. Res., 27, 693-702.
42. Ravingerova, T., Tribulova, N., Slezak, J. & Curtis, M.J. (1995). Brief, intermediate and prolonged ischemia in the isolated crystalloid perfused rat heart: Relationship between susceptibility to arrhythmias and degree of ultrastructural injury. J. Mol. Cell. Cardiol., 27, 1937-1951.
43. Rees, S.A. & Curtis, M.J. (1995). Pharmacological analysis in rat of the role of the ATPsensitive potassium channel as a potential target for antifibrillatory intervention in acute myocardial ischaemia. J. Cardiovasc. Pharmacol., 26, 280-288.
44. Rees, S.A. & Curtis, M.J. (1993a). Tacrine inhibits ventricular fibrillation induced by ischaemia and reperfusion and widens QT interval in rat. Cardiovasc. Res., 27, 453-458.
45. Rees, S.A., Tsuchihashi, K., Hearse, D.J. & Curtis, M.J. (1993b). Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate. QT interval, and ischaemia-induced ventricular fibrillation in rats. J. Cardiovasc. Pharmacol., 22, 343-349.
46. Ridley, P.D., Yacoub, M.H. & Curtis, M.J. (1992). A modified model of global ischaemia: Application to the study of syncytial mechanisms of arrhythmogenesis. Cardiovasc. Res., 26, 309-315.
47. Rushmer, R.F., Watson, N., Harding, D. & Baker, D. (1963). Effects of acute coronary occlusion on performance of right and left ventricles in intact unanesthetized dogs. Am. J. Cardiol., 52, 41C-46C.
48. Saint, K.M., Abraham, S., MacLeod, B.A., McGough, J., Yoshida, N. & Walker, M.J. (1992). Ischemic but not reperfusion arrhythmias depend upon serum potassium concentration. J. Mol. Cell. Cardiol., 24, 701-709.
49. Shattock, M.J., Miller, M.J.I., Bray, D.C. & Waldron, C.B. (1997). An electronic feed-back circuit to control a peristaltic pump for constant-pressure perfusion of isolated hearts or other organs. J. Physiol., 505, 4P.
50. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J. & Klenk, D.C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76-85.
51. Tait, A.R. & Larson, L.O. (1991). Resuscitation fluids for the treatment of hemorrhagic shock in dogs: Effects on myocardial blood flow and oxygen transport. Crit. Care Med., 19, 1561-1565.
52. Teoh, K.H., Fremes, S.E., Weisel, R.D., Christakis, G.T., Teasdale, S.J., Madonik, M.M., Ivanov, J., Mee, A.V. & Wong, P.Y. (1987). Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization. J. Thorac. Cardiovasc. Surg., 93, 120-126.
53. Waldo, A.L., Camm, A.J., DeRuyter, H., Friedman, P.L., MacNeil, D.J., Pauls, J.F., Pitt, B., Pratt, C.M., Schwartz, P.J. & Veltri, E.P. (1996). Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet, 348, 7-12.
54. Walker, M.J., Curtis, M.J., Hearse, D.J., Campbell, R.W., Janse, M.J., Yellon, D.M., Cobbe, S.M., Coker, S.J., Harness, J.B., Harron, D.W., Higgins, A.J., Julian, D.G., Lab, M.J., Manning, A.S., Northover, B.J., Parratt, J.R., Riermersma, R.A., Riva, E., Russell, D.C., Sheridan, D.J., Winslow, E. & Woodward, B. (1988). The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc. Res., 22, 447-455.
55. Withington, D.E, & Aranda, J.V. (1997). Histamine release during cardiopulmonary bypass in neonates and infants. Can. J. Anaesth., 44, 610-616.